Open AccessUtility of the trough plasma imatinib level monitoring at two time points in patients with the chronic myeloid leukemia-chronic phase
Author(s) -
Sanjeev Sharma,
Suman Kumar,
A R Vijayakumar,
Tulika Seth,
Pravas Mishra,
Manoranjan Mahapatra,
Sudha Sazawal,
Thirumurthy Velpandian,
Renu Saxena
Publication year - 2014
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.136583
Subject(s) - imatinib , myeloid leukemia , medicine , trough level , imatinib mesylate , chronic myelogenous leukemia , oncology , leukemia , gastroenterology , pharmacology , immunology , transplantation , tacrolimus
Plasma imatinib levels vary widely in patients with the chronic myeloid leukemia-chronic phase, and studies have shown improved hematological, cytogenetic, and molecular responses in patients with the higher trough imatinib levels.